Acurx Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 13, 2025 Conference Call and Provide Business Update
STATEN ISLAND, N.Y., April 30, 2025 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical... Read more.
Innovations and AI projects dominated at the Davos Communications Awards 2025, organized by WCFA in the Swiss Alps
DAVOS, Switzerland, April 30, 2025 /PRNewswire/ — The Davos Communications Awards 2025 celebrated excellence in global public relations and communications... Read more.
KuCoin Commits $2 Billion to “Trust Project” to Strengthen Confidence in Crypto; CEO BC Wong Announces Initiative at TOKEN2049
VICTORIA, Seychelles, April 30, 2025 /PRNewswire/ — KuCoin, a leading global cryptocurrency exchange, has committed $2 billion to its newly launched “Trust... Read more.
Daisy continues expansion into Boulder, capitalizing on Colorado’s growing home technology market
New franchisee brings significant business experience and knowledge of smart home sector to Boulder and Castle Rock, CO communities COSTA MESA, Calif., April 30,... Read more.
Garmin announces first quarter 2025 results
Company reports record first quarter operating results and maintains full year EPS guidance SCHAFFHAUSEN, Switzerland, April 30, 2025 /PRNewswire/ — Garmin®... Read more.
DFIN Reports First-Quarter 2025 Results
CHICAGO, April 30, 2025 /PRNewswire/ — Donnelley Financial Solutions, Inc. (NYSE: DFIN) (the “Company” or “DFIN”) today reported financial... Read more.
Altair to Showcase Next-Gen Simulation at ATCx Simulate at the Speed of Design Virtual Event
Event will highlight how small and medium-sized businesses can leverage simulation to reduce risk, cost, and development cycles TROY, Mich., April 30, 2025 /PRNewswire/... Read more.
Avista Therapeutics Announces Oral Presentation at Association for Research in Vision and Ophthalmology 2025 Annual Meeting
PITTSBURGH, April 30, 2025 /PRNewswire/ — Avista Therapeutics, a pre-clinical-stage biotechnology company developing innovative gene therapies for rare ophthalmic... Read more.
Wolters Kluwer UpToDate® Integrated into Tom™ to Strengthen Primary Care as a Service
Collaboration brings evidence-based recommendations into Lumeris’ AI-powered platform to support physicians and improve outcomes ST. LOUIS, April 30, 2025... Read more.
Blackbaud Announces 2025 First Quarter Results
Company Reiterates FY 2025 Financial Guidance CHARLESTON, S.C., April 30, 2025 /PRNewswire/ — Blackbaud (NASDAQ: BLKB), the leading provider of software for... Read more.